Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
---|
12/29/2004 | CN1557469A Natural calcium replenishing nutrient |
12/29/2004 | CN1557468A Preparation method and application of antiphlogistic factor |
12/29/2004 | CN1557466A Marrow peptide preparation and its preparing process |
12/29/2004 | CN1557465A Spleen aminopeptide preparation and its preparing method |
12/29/2004 | CN1557345A Preparation and technique for making compound leech eye drip |
12/29/2004 | CN1557344A Processing technique for making active calcium by java tilapia bone |
12/29/2004 | CN1557343A Yin-nourishing and heat-clearing, mental anxiety easing preparation |
12/29/2004 | CN1557342A Antisenescent and sexual function improving preparation |
12/29/2004 | CN1557341A Preparing process of multiple biologically active substance containing formulation |
12/29/2004 | CN1557340A Growth factor and immuneglobin preparation |
12/29/2004 | CN1557339A Preparation for preventing and treating tympanitis and dental caries |
12/29/2004 | CN1557338A Preparation for preventing and treating rheumatic arthritis and other autoimmune disease |
12/29/2004 | CN1557337A Preparation and application of natural biologically active components with lowering down blood pressure function |
12/29/2004 | CN1557336A Cardiovascular and respiratory function regulating biological active prescription |
12/29/2004 | CN1557281A Skin apolexis preventing delaying polypeptide and compositions |
12/29/2004 | CN1557206A Low value fresh water fish whole utilization process method |
12/29/2004 | CN1182399C Removal of prions from blood, plasma and other liquids |
12/29/2004 | CN1182247C Sequence-specific DNA recombination in eukaryotic cells |
12/29/2004 | CN1181890C Use of enterobacterium protein OmpA in the preparation of antigen presentation cells specified targeting medicine |
12/29/2004 | CN1181882C Ointment of Chinese herbal medicine for reactivating nerve and its manufacturing method |
12/29/2004 | CN1181877C Medicine for treating diabetic nephropathy and its preparing method |
12/29/2004 | CN1181868C Chinese medicine preparation for treating thromboangiitis obliterans |
12/29/2004 | CN1181867C Chinese medicine preparation for treating varicosity |
12/29/2004 | CN1181863C Chinese traditional medicinal tablet for treating kidney disease |
12/29/2004 | CN1181862C Medicinal tablet for treating prostatitis and its preparing method |
12/29/2004 | CN1181861C Spray agent for treating tendon and bone injury |
12/29/2004 | CN1181856C Medicine with functions of postponing senility and loosening the bowel to relieve constipation |
12/29/2004 | CN1181852C Medicine for treating bladder cancer |
12/29/2004 | CN1181850C Chinese medicinal preparation for treating cadiovascular and cerebrovascular diseases |
12/29/2004 | CN1181848C Syphilis treating Chinese medicine |
12/29/2004 | CN1181844C Medicine for treating burns and scalds and its preparation process |
12/29/2004 | CN1181843C Traditional Chinese medicine composition for curing rheumatism |
12/29/2004 | CN1181841C Bladder cancer treating Chinese medicine |
12/29/2004 | CN1181838C Medicine for treating gastroduodenal ulcer |
12/29/2004 | CN1181835C Chinese medicine preparation for treating rheumatism and rheumatoid disease |
12/29/2004 | CN1181833C Instant sugar reducing medicine |
12/29/2004 | CN1181831C Medicine with functions of reducing sugar and reducing blood-fat and its preparation method |
12/29/2004 | CN1181830C Yunnan Heiyao and its application in treating tumors |
12/29/2004 | CA2570407A1 Methods and compositions for modulating stem cell growth and differentiation |
12/29/2004 | CA2529652A1 Leukocyte cell banks |
12/29/2004 | CA2529573A1 Porcine islets cultured with porcine sertoli cells for xenotransplantation |
12/29/2004 | CA2529288A1 Composition for lowering serum uric acid level |
12/29/2004 | CA2527626A1 Method of generating islet beta-cells from exocrine pancreatic cells |
12/29/2004 | CA2525847A1 Tissue modeling in embryonic stem (es) cell system |
12/29/2004 | CA2524712A1 Processing of platelet-containing biological fluids |
12/28/2004 | US6835711 Use of poly-Glu,Tyr for neuroprotective therapy |
12/28/2004 | US6835567 PNS cell lines and methods of use therefor |
12/28/2004 | US6835566 Culturing lineage committed human cells under liquid culture conditions, including replacement of liquid culture medium at a rate and for a time sufficient to obtain human lineage committed cells; skin, bone marrow replacements, therapy |
12/28/2004 | US6835377 Regenerating articular cartilage defects by administering cultured human mesenchymal stem cells |
12/28/2004 | US6835376 Lactobacillus paracasei strain for preventing diarrhea caused by pathogenic bacteria |
12/23/2004 | WO2004111250A1 Recombinant adeno-associated virus vector for treatment of alzheimer disease |
12/23/2004 | WO2004111212A1 Process for producing tissue cell from pluripotent stem cell derived from iris pigment epithelial cell of animal and tissue cell obtained by the process |
12/23/2004 | WO2004111210A1 Enhancement of oligodendrocyte differentiation |
12/23/2004 | WO2004111208A1 Cartilage-derived stem cells and applications thereof |
12/23/2004 | WO2004110512A2 A method for cell implantation |
12/23/2004 | WO2004110475A1 Connective tissue derived polypeptides |
12/23/2004 | WO2004110466A2 Pediocin-producing pediococci |
12/23/2004 | WO2004110465A1 An extract of faeces bombycis and the preparation method thereof, as well as an apparatus for diagnosing or treating malignant tumours |
12/23/2004 | WO2004110372A2 Room temperature storage of organs |
12/23/2004 | WO2004063356A3 Persistent expression of candidate molecule in proliferating stem and progenitor cells for delivery of therapeutic products |
12/23/2004 | WO2004062554A3 Enhancement of dopaminergic neuron generation and survital |
12/23/2004 | WO2004045563A3 Method of treatment of myocardial infarction |
12/23/2004 | WO2004032823A3 Treatment and rehydration composition which is used to limit the side effects of gastro-enteritis in adults |
12/23/2004 | WO2004016747A3 Bone marrow cell differentiation |
12/23/2004 | WO2003106692A3 Methods for the identification of all-antigens and their use for cancer therapy and transplantation |
12/23/2004 | WO2003077852A8 CARTILAGE REGENERATION USING CHONDROCYTE AND TGF-β |
12/23/2004 | US20040260061 Continuous, normal human t-lymphocyte cell lines comprising a recombinant immune receptor with defined antigen specificity |
12/23/2004 | US20040259841 Low molecular weight; nutritional supplement; softening of human skin;orally administering |
12/23/2004 | US20040259795 Reducing sepsis; binding polypeptide to monoclonal antibody ; intensify gene expression; wound healing agents |
12/23/2004 | US20040259790 Methods for identifying and administering agents that bias the immune response via dendritic cells |
12/23/2004 | US20040259788 Use of neurotoxin therapy for treatment of urologic and related disorders |
12/23/2004 | US20040259783 Pharmaceutical compositions of marine sponge microciona prolifera |
12/23/2004 | US20040259254 for use treating various neurodegenerative or brain disorders or injuries via cell transplantation; incubating the cell derived from a mononuclear cell fraction isolated from bone marrow fluid or umbilical blood in a basal culture medium at given temperature range |
12/23/2004 | US20040259246 Liver cell progenitor and use for treatment of liver diseases |
12/23/2004 | US20040259244 converting differentiated non-hormone producing pancreatic cells into differentiated hormone producing cells by converting said non-hormone cells into stem cells; and then culturing stem cells under conditions which differentiate them into hormone-producing cells; use in diabetes therapy |
12/23/2004 | US20040259227 Strains of bacteria and pharmaceutical composition containing one or more of such strains and use of same for preventing and treating diseases asociated with or caused by altered metabolism of bile acids |
12/23/2004 | US20040259201 Recombinant surfactant protein D compositions and methods of use thereof |
12/23/2004 | US20040259196 T cell receptor variants expressed in mesenchymal cells and uses thereof |
12/23/2004 | US20040258765 Topical antiulcer and wound healing agent comprising bee pollen, bee propolis, honey, and/or royal jelly; and caffeine; health beverages; skin disorders, herpes viral infections; spray, shampoo, soap, lipstick, or adhesive bandages |
12/23/2004 | US20040258708 Cytotoxic T-cell epitopes of papillomavirus L1 protein and their use in diagnostics and therapy |
12/23/2004 | US20040258673 Elective collection and banking of autologous peripheral blood stem cells |
12/23/2004 | US20040258672 Graft acceptance through manipulation of thymic regeneration |
12/23/2004 | US20040258670 Introducing enriched human endothelial generating cells and mesenchymal stem cells; enhancing vasculogenesis and collateralization around blocked and/or narrowed vessels |
12/23/2004 | US20040258669 Enhancing viability, imparting apoptosis resistance; treating cardiac disorders; reducing scar formation |
12/23/2004 | US20040258667 Herpes simplex virus expressing foreign genes and method for treating cancers therewith |
12/23/2004 | US20040258661 Generation of use of tc1 and tc2 cells |
12/23/2004 | US20040258660 Tumor necrosis factor alpha analogues having three dimensional structure of similar to proteins from which they are derived; facilitating correct folding |
12/23/2004 | CA2528679A1 Cartilage-derived stem cells and applications thereof |
12/23/2004 | CA2528399A1 A method for cell implantation |
12/23/2004 | CA2528235A1 Connective tissue derived polypeptides |
12/23/2004 | CA2527863A1 Cell surface protein associated with human chronic lymphocytic leukemia |
12/23/2004 | CA2527847A1 Enhancement of oligodendrocyte differentiation |
12/23/2004 | CA2527832A1 1.3.4-triaza-phenalene and 1,3,4,6-tetraazaphenalene derivatives |
12/23/2004 | CA2527822A1 Room temperature storage of organs |
12/23/2004 | CA2525778A1 T cell epitopes useful in a severe acute respiratory syndrome (sars) virus vaccine and as diagnostic tools and methods for identifying same |
12/22/2004 | EP1489164A1 Recombinant vaccinia viruses with modified F3 genes, uses thereof |
12/22/2004 | EP1488805A2 CD28 pathway immunoregulation |
12/22/2004 | EP1488803A1 Neurotoxic component of botulinum toxins for treating neuromuscular disorders |
12/22/2004 | EP1487984A1 Dna vaccines encoding cea and a cd40 ligand and methods of use thereof |
12/22/2004 | EP1487983A2 Prevention of recurrence and metastasis of cancer |